, Tracking Stock Market Picks
Enter Symbol:
Gopro Inc. (GPRO) [hlAlert]

down 26.34 %

Gen-probe Incorporated (GPRO) rated Overweight with price target $76 by Lehman Brothers

Posted on: Thursday,  Feb 14, 2008  8:25 AM ET by Lehman Brothers

Lehman Brothers rated Overweight Gopro Inc. (NASDAQ: GPRO) on 02/14/2008. Previously Lehman Brothers rated Buy Gopro Inc. (NASDAQ: GPRO) on 08/02/2007.,
when the stock price was $64.84. Since then, Gopro Inc. has lost 26.34% as of 01/14/2016's recent price of $47.76.
If you would have followed the previous Lehman Brothers's recommendation on GPRO, you would have lost 26.34% of your investment in 3087 days.

Gen-Probe Inc. is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing (NAT) products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals for more than 40 products that detect a wide variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections.

Lehman Brothers Holdings Inc. has filed for bankruptcy protection in the U.S.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/14/2008 8:25 AM Buy
54.04 76.00
as of 12/24/2008
1 Week down  -3.53 %
1 Month up  2.49 %
3 Months up  12.57 %
1 YTD up  6.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/31/2007 11:25 AM Buy
67.12 78.00
10/17/2007 9:25 AM Buy
69.61 73.00
8/2/2007 9:25 AM Buy
64.84 67.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy